Drug resistance in castration resistant prostate cancer: resistance mechanisms and emerging treatment strategies

gan Armstrong, Cameron M, Gao, Allen C
Cyhoeddwyd yn Am J Clin Exp Urol (2015)

CCN3-EZH2-AR feedback loop: new targets for enzalutamide and castration resistant prostate cancer

gan Armstrong, Cameron M., Gao, Allen C.
Cyhoeddwyd yn J Cell Commun Signal (2017)

Adaptive pathways and emerging strategies overcoming treatment resistance in castration resistant prostate cancer

gan Armstrong, Cameron M., Gao, Allen C.
Cyhoeddwyd yn Asian J Urol (2016)

Current strategies for targeting the activity of androgen receptor variants

gan Armstrong, Cameron M., Gao, Allen C.
Cyhoeddwyd yn Asian J Urol (2019)

Estradiol Has Differential Effects on Acute Colonic Inflammation in the Presence and Absence of Estrogen Receptor β Expression

gan Armstrong, Cameron M., Allred, Kimberly F., Weeks, Brad R., Chapkin, Robert S., Allred, Clinton D.
Cyhoeddwyd yn Dig Dis Sci (2017)

Inhibition of AKR1C3 activation overcomes resistance to abiraterone in advanced prostate cancer

gan Liu, Chengfei, Armstrong, Cameron M., Lou, Wei, Lombard, Alan, Evans, Christopher P., Gao, Allen C.
Cyhoeddwyd yn Mol Cancer Ther (2016)

MicroRNA-181a promotes docetaxel resistance in prostate cancer cells

gan Armstrong, Cameron M., Liu, Chengfei, Lou, Wei, Lombard, Alan P., Evans, Christopher P, Gao, Allen C.
Cyhoeddwyd yn Prostate (2017)

Wntless promotes cellular viability and resistance to enzalutamide in castration-resistant prostate cancer cells

gan Lombard, Alan P, Liu, Chengfei, Armstrong, Cameron M, D’Abronzo, Leandro S, Lou, Wei, Evans, Christopher P, Gao, Allen C
Cyhoeddwyd yn Am J Clin Exp Urol (2019)

ABCB1 mediates cabazitaxel-docetaxel cross-resistance in advanced prostate cancer

gan Lombard, Alan P., Liu, Chengfei, Armstrong, Cameron M., Cucchiara, Vito, Gu, Xinwei, Lou, Wei, Evans, Christopher P., Gao, Allen C.
Cyhoeddwyd yn Mol Cancer Ther (2017)

Intra vs Inter Cross-Resistance Determines Treatment Sequence between Taxane and AR-Targeting Therapies in Advanced Prostate Cancer

gan Lombard, Alan P., Liu, Liangren, Cucchiara, Vito, Liu, Chengfei, Armstrong, Cameron M., Zhao, Ruining, Yang, Joy C., Lou, Wei, Evans, Christopher P., Gao, Allen C.
Cyhoeddwyd yn Mol Cancer Ther (2018)

Overexpressed ABCB1 Induces Olaparib-Taxane Cross-Resistance in Advanced Prostate Cancer()

gan Lombard, Alan P, Liu, Chengfei, Armstrong, Cameron M, D'Abronzo, Leandro S, Lou, Wei, Chen, Hongwu, Dall'Era, Marc, Ghosh, Paramita M, Evans, Christopher P, Gao, Allen C
Cyhoeddwyd yn Transl Oncol (2019)

Niclosamide and bicalutamide combination treatment overcomes enzalutamide and bicalutamide resistant prostate cancer

gan Liu, Chengfei, Armstrong, Cameron M., Lou, Wei, Lombard, Alan P., Cucchiara, Vito, Gu, Xinwei, Yang, Joy C., Nadiminty, Nagalakshmi, Pan, Chong-xian, Evans, Christopher P., Gao, Allen C.
Cyhoeddwyd yn Mol Cancer Ther (2017)

AKR1C3 promotes AR-V7 protein stabilization and confers resistance to AR-targeted therapies in advanced prostate cancer

gan Liu, Chengfei, Yang, Joy C., Armstrong, Cameron M., Lou, Wei, Liu, Liangren, Qiu, Xiaomin, Zou, Binhao, Lombard, Alan P., D’Abronzo, Leandro S, Evans, Christopher P., Gao, Allen C.
Cyhoeddwyd yn Mol Cancer Ther (2019)

Steroid sulfatase stimulates intracrine androgen synthesis and is a therapeutic target for advanced prostate cancer

gan Armstrong, Cameron M., Liu, Chengfei, Liu, Liangren, Yang, Joy C., Lou, Wei, Zhao, Ruining, Ning, Shu, Lombard, Alan P., Zhao, Jinge, D’Abronzo, Leandro S, Evans, Christopher P., Li, Pui-Kai, Gao, Allen C.
Cyhoeddwyd yn Clin Cancer Res (2020)

Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer

gan Liu, Chengfei, Lou, Wei, Yang, Joy C., Liu, Liangren, Armstrong, Cameron M., Lombard, Alan P., Zhao, Ruining, Noel, Onika D. V., Tepper, Clifford G., Chen, Hong-Wu, Dall’Era, Marc, Evans, Christopher P., Gao, Allen C.
Cyhoeddwyd yn Nat Commun (2018)